Glial-neuronal interactions in Alzheimer's disease: The potential role of a 'cytokine cycle' in disease progression

Brain Pathology

Volumn 8, Issue 1, 1998, Pages 65-72

  Griffin, W Sue T ⁱ   Sheng, J G ^b,g   Royston, M C ^d   Gentleman, S M ^d   McKenzie, J E ^d   Graham, D I ^e   Roberts, G W ^f,h   Mrak, R E ^a,c  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^c UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^d IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^e SOUTHERN GENERAL HOSPITAL   (United Kingdom)

^f Opine Consultancy   (United Kingdom)

^g SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

^h CENTRAL ARKANSAS VETERANS HEALTHCARE SYSTEM   (United States)

ⁱ NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTICHYMOTRYPSIN; AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; ANTIINFLAMMATORY AGENT; APOLIPOPROTEIN E; CYTOKINE; INTERLEUKIN 1; PROTEIN; PROTEIN S 100;

AGING; ALZHEIMER DISEASE; DISEASE COURSE; EPILEPSY; FEEDBACK SYSTEM; GLIA; HEAD INJURY; HUMAN; INFLAMMATION; NERVE CELL; NONHUMAN; REVIEW; RISK FACTOR;

EID: 0031983986     PISSN: 10156305     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1750-3639.1998.tb00136.x     Document Type: Review

References (70)

1. Abe K, Tanzi RE, Kogure K (1991) Selective induction of Kunitz-type protease inhibitor domain containing β-APP mRNA after persistent focal ischaemia in rat cerebral cortex. Neurosci Lett 125: 172-74
2. Allore R, O'Hanlon D, Price R, Neilson K, Willard HF, Cox DR, Marks A, Dunn RJ (1988) Gene encoding the β subunit of S100 protein is on chromosome 21: Implications for Down syndrome. Science 239: 1311-13
3. Andersen K, Launer LJ, Ott A, Hoes AW, Breteler MM, Hofman A (1995) Do nonsteroidal anti-inflammatory drugs decrease the risk for Alzheimer's disease? The Rotterdam Study. Neurology 45: 1441-1445
4. Barger SW, Harmon AD (1997) Microglial activation by Alzheimer amyloid precursor protein and modulation by apolipoprotein E. Nature 388: 878-881
5. Barger SW, Van Eldik LJ (1992) S100β stimulates calcium fluxes in glial and neuronal cells. J Biol Chem 267: 9689-94
6. Bhattacharyya A, Oppenheim RW, Prevette D, Moore BW, Brackenbury R. Ratner N (1992) S100 is present in developing chicken neurons and Schwann cells and promotes neuron survival in vivo. J Neurobiol 23: 451-66
7. Breitner JC, Gau BA, Welsh KA, Plassman BL, McDonald WM, Helms MJ, Anthony JC (1994) Inverse association of anti-inflammatory treatments and Alzheimer's disease: initial results of a co-twin control study. Neurology 44: 227-232
8. Breitner JCS, Welsh KA, Helms MJ, Gaskell PC, Gau BA, Roses AD (1995) Delayed onset of Alzheimer's disease with nonsteroidal anti-inflammatory and histamine H2 blocking drugs. Neurobiol Aging 16: 523-530
9. Brenneman DE, Page SW, Schultzberg M, Thomas FS, Zelazowski P, Burnet P, Avidor R. Sternberg EM (1992) A decomposition product of a contaminant implicated in L-tryptophan eosinophilia myalgia syndrome affects spinal cord neuronal cell death and survival through stereospecific, maturation and partly interleukin-1-dependent mechanisms. J Pharmacol Exp Ther 266: 1029-35
10. Brenneman DE, Schultzberg M, Bartfai T, Gozes I (1992) Cytokine regulation of neuronal survival. J Neurochem 58: 454-60
11. Buxbaurn JD, Oishi M, Chen HI, Pinkas-Kramarski R, Jaffe EA, Gandy SE, Greengard P (1992) Cholinergic agonists and interleukin 1 regulate processing and secretion of the Alzheimer β/A4 amyloid protein precursor. Proc Natl Acad Sci USA 89: 10075-10078
12. Cacabelos R, Alvarez XA, Fernandez-Novoa L, Franco A, Mangues R, Pellicer A, Nishimura T (1994) Brain interleukin-1 beta in Alzheimer's disease and vascular dementia. Met Findings Exp Clin Pharm 16: 141-51
13. Cork LC, Masters C, Beyreuther K, Price DL (1990) Development of senile plaques: relationships of neuronal abnormalities and amyloid deposits. Am J Pathol 137: 1383-92
14. 1-antichymotrypsin and apolipoprotein E is induced in astrocytes by IL-1. Neuron 14: 447-56
15. Dinarello CA, Wolff SM (1993) The role of interleukin-1 in disease. N Engl J Med 328: 106-13
16. Forloni G, Demicheli F, Giorgi S, Bendotti C, Angeretti N (1992) Expression of amyloid precursor protein mRNAs in endothelial, neuronal and glial cells: modulation by interleukin-1. Brain Res Molec Brain Res 16: 128-134
17. Ganter S, Northoff H, Mannel D, Gebicke-Harter PJ (1992) Growth control of cultured microglia. J Neurosci Res 33: 218-30
18. Gentleman SM, Graham DI, Roberts GW (1993) Molecular pathology of head trauma: altered βAPP metabolism and the aetiology of Alzheimer's disease. Prog Brain Res 96: 237-246
19. Gentleman SM, Nash MJ, Sweeting CJ, Graham DI, Roberts GW (1993) β-Amyloid precursor protein (β-APP) as a marker for axonal injury after head injury. Neurosci Lett 160: 139-44
20. Giuhan D, Lachman LB (1985) lnterleukin-1 stimulation of astroglial proliferation after brain injury. Science 228: 497-99
21. Giulian D, Woodward J, Young DG, Krebs JF, Lachman LB (1988) lnterleukin-1 injected into mammalian brain stimulates astrogliosis and neovascularization. J Neurosci 8: 2485-2490
22. Goldgaber D, Harns HW, Hla T, Maciag T, Donnelly RG, Jacobsen JS, Vitek MR Gajdusek DC (1989) Interleukin 1 regulates synthesis of amyloid beta-protein precursor mRNA in human endothelial cells. Proc Natl Acad Sci USA 86: 7606-7610
23. Gouras GK, Relkin NR, Sweeney D, Munoz DG, Mackenzie IR, Gandy S. (1997) Increased apolipoprotein E epsilon 4 in epilepsy with senile plaques. Ann Neurol 41: 402-404
24. Graham DI, Gentleman SM, Lynch A, Landon M, Roberts GW (1995) Distribution of beta amyloid protein in the brain following severe head injury. Neuropath Appl Neurobiol 1: 27-34
25. Griffin WST, Sheng JG, Gentleman SM, Graham DI, Mrak RE, Roberts GW (1994) Microglial interleukin-1α expression in human head injury: correlations with neuronal and neuritic β-amyloid precursor protein expression. Neurosci Lett 176: 133-36
26. Griffin WST, Sheng JG, Roberts GW, Mrak RE (1995) lnterleukin-1 expression in different plaque types in Alzheimer's disease: significance in plaque evolution. J Neuropathol Exp Neurol 54: 276-81
27. Griffin WST, Stanley LC, Ling C, White L, MacLeod V, Perrot LJ, White CD III, Araoz C (1989) Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease. Proc Natl Acad Sci USA 86: 7611-15
28. Griffin WST, Yeralan O, Boop F, Rovnaghi CR, Sheng JG, Mrak RE, Van Eldik LC (1995) Overexpression of the neurotrophic cytokine S100β in human temporal lobe epilepsy. J Neurochem 65: 228-33
29. Hetier E, Ayala J, Denefle P, Bousseau A, Rouget P, Mallat M, Prochiantz A (1988) Brain macrophages synthesize interleukin-1 and interleukin-1 mRNAs in vitro. J Neurosci Res 21: 391-97
30. Hu J, Castets F, Guevara JL, Van Eldik LJ (1996) S100β stimulates inducible nitric oxide synthase activity and mRNA levels in rat cortical astrocytes. J Biol Chem 271: 2543-47
31. Ito K, Ishikawa Y, Skinner RD, Mrak RE, Morrison-Bogorad M, Mukawa J, Griffin WST (1997) Lesioning of the inferior olive using a ventral surgical approach: characterization of temporal and spatial responses at the lesion site and in cerebellum. Molec Chem Neuropathol 31: 245-264.
32. Kligman D, Marshak DR (1985) Purification and characterization of a neurite extension factor from bovine brain. Proc Natl Acad Sci USA 82: 7136-39
33. Lee SC, Liu W, Dickson DW, Brosnan CF, Berman JW (1993) Cytokine production by human fetal microglia and astrocytes. Differential induction by lipopolysaccharide and IL-1 beta. J Immunol 150: 2659-67
34. Mackenzie IRA, Miller LA (1994) Senile plaques in temporal lobe epilepsy. Acta Neuropathol 87: 504-510
35. Manuelidis EE, Manuelidis L (1989) Suggested links between different types of dementias: Creutzfeldt-Jakob disease, Alzheimer disease, and retroviral CNS infections. Alzheimer Dis Assoc Disord 3: 100-9
36. Marshak DR, Pesce SA, Stanley LC, Griffin WST (1992) Increased S100β neurotrophic activity in Alzheimer's disease temporal lobe. Neurobiol Aging 13: 1-7
37. Mattson MR Cheng B, Davis D, Bryant K, Lieberburg I, Rydel RE (1992) β-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. J Neurosci 12: 376-89
38. Mayeux R, Ottman R, Maestre G, Ngai C, Tang MX, Ginsberg H, Chun M, Tycko B, Shelanski M (1995) Synergistic effects of traumatic head injury and apolipoprotein-E in patients with Alzheimer's disease. Neurology 45: 555-57
39. Mayeux R, Ottman R, Tang MX, Noboa-Bauza L, Marder K, Gurland B, Stern Y (1993) Genetic susceptibility and head injury as risk factors for Alzheimer's disease among community-dwelling elderly persons and their first-degree relatives. Ann Neurol 33: 494-501
40. McKenzie JE, Gentleman SM, Roberts GW, Graham DI, Royston MC (1994) increased numbers of βAPP-immunoreactive neurons in the entorhinal cortex after head injury. Neuroreport 6: 161-64
41. Mortimer JA, van Duijn CM, Chandra V, Fratiglioni L, Graves AB, Heyman A, Jorm AF, Kokmen E, Kondo K, Rocca WA, et al (1991) Head trauma as a risk factor for Alzheimer's disease: a collaborative re-analysis of case-control studies. EURODEM Risk Factors Research Group. Int J Epidemiol 20: S28-35
42. Mrak RE, Sheng JG, Griffin WST (1995) Glial cytokines in Alzheimer's disease: review and pathogenic implications. Human Pathol 26: 816-23
43. Mrak RE, Sheng JG, Griffin WST (1996) Correlation of astrocytic S100β expression with dystrophic neuntes in amyloid plaques of Alzheimer's disease. J Neuropathol Exp Neurol 55: 273-79
44. - microglia, increase with age in normal human brain. Soc Neurosci Abstr 22 (Part 1): 213
45. Nicoll JAR, Roberts GW, Graham DI (1995) Apolipoprotein Eε4 alltele is associated with deposition of amyloid β-protein following head injury. Nature Med 1: 135-137
46. Pluta R, Kida E, Lossinsky AS, Golabak AA, Mossakowski MJ, Wisniewski HM (1994) Complete cerebral ischemia with short-term survival in rats induced by cardiac arrest. Extracellular accumulation of Alzheimer's β-amyloid protein precursor in the brain. Brain Res 649: 323-28
47. Pulliam L, Herndier BG, Tang NM, McGrath MS (1991) Human immunodeficiency virus-mfected macrophages produce soluble factors that cause histological and neurochemical alterations in cultured human brains. J Clin Invest 87: 503-12
48. Reeves RH, Yao J, Crawley MR, Buck S, Zhang X, Yarowski P, Gearhart JD (1994) Astrocytosis and axonal proliferation in the hippocampus of S100β transgenic mice. Proc Natl Acad Sci USA 91: 5359-63
49. Rich JB, Rasmusson DX, Folstein MF, Carson KA, Kawas C, Brandt J (1995) Nonsteroidal anti-inflammatory drugs in Alzheimer's disease. Neurology 45: 51-55
50. Roberts GW, Allsop D, Bruton CJ (1990) The occult aftermath of boxing. J Neurol Neurosurg Psych 53: 373-378
51. Roberts GW, Gentleman SM, Lynch A, Graham DI (1991) βA-4 amyloid protein deposition in brain after head trauma. Lancet 338: 1422-1423
52. Roberts GW, Gentleman SM, Lynch A, Murray L, Landen M, Graham DI (1994) β-Amyloid protein deposition in the brain following severe head injury: implications for the pathogenesis of Alzheimer's disease. J Neurol Neurosurg Psychiat 7: 419-425
53. Rogers J, Cooper NR, Webster S, Schulte J, McGeer PL, Styren SD, Civin WH, Brachova L, Bradt B, Ward P (1992) Complement activation by β-amyloid in Alzheimer disease. Proc Natl Acad Sci USA 89: 10016-20
54. Rothwell NJ (1991) Functions and mechanisms of interleukin 1 in the brain. TiPS 12: 430-36
55. Royston MC, Rothwell NJ, Roberts GW (1992) Alzheimer's disease: Pathology to potential treatment? TiPS, 13: 131-33
56. Rozemuller JM, Eikelenboom P, Stam FC, Beyreuther K, Masters CL (1989) A4 protein in Alzheimer's disease: primary and secondary cellular events in extracellular amyloid deposition. J Neuropathol Exp Neurol 48: 674-91
57. Sebire G, Emilie D, Wallon C, Hery C, Devergne O, Delfraissy JF, Galanaud P, Tardieu M (1993) In vitro production of IL-6, IL-1 beta, and tumor necrosis factor-alpha by human embryonic microglial and neural cells. J Immunol 150: 1517-23
58. Selinfreund RH, Barger SW, Pledger WJ, Van Eldik LJ (1991) Neurotrophic protein S100β stimulates glial cell proliferation. Proc Natl Acad Sci USA 88: 3554-3558
59. Selinfreund RH, Barger SW, Welsh MJ, Van Eldik LJ (1990) Antisense inhibition of glial S100β production results in alterations in cell morphology, cytoskeletal organization and cell proliferation. J Cell Biol 111: 2021-28
60. Selkoe DJ (1994) Alzheimer's disease: a central role for amyloid. J Neuropathol Exp Neurol 53: 438-447
61. Sheng JG, Boop FA, Mrak RE, Griffin WST (1994) Increased neuronal β-amyloid precursor protein expression in human temporal lobe epilepsy : Association with interleukin-1 alpha immunoreactivity. J Neurochem 63: 1872-79
62. Sheng JG, Ito K, Skinner RD, Mrak RE, Rovnaghi CR, Van Eldik LJ. Griffin WST (1996) In vivo and in vitro evidence supporting a role for the inflammatory cytokine interleukin-1 as a driving force in Alzheimer pathogenesis. Neurobiol Aging 17: 761-66
63. Sheng JG, Mrak RE, Griffin WST (1994) S100β protein expression in Alzheimer's disease: potential role in the pathogenesis of neuritic plaques J Neurosci Res 39: 398-403
64. Sheng JG, Mrak RE, Griffin WST (1995) lnterleukin-1α expression in brain regions in Alzheimer's disease: Correlation with neuritic plaque distribution. Neuropathol Appl Neurobiol 21: 290-301
65. Sheng FG, Mrak RE, Griffin WST (1996) Apolipoprotein E distribution among different plaque types in Alzheimer's disease: implications for its role in plaque progression. Neuropathol Appl Neurobiol 22: 334-41
66. - microglia and S100β- astrocytes with neurofibrillary tangle stages. J Neuropathol Exp Neurol 56: 285-90
67. Sheng JG, Mrak RE, Rovnaghi CR, Kozlowska E, Van Eldik LJ, Griffin WST (1996) Human brain S100β and S100β mRNA expression increases with age: Pathogenic implications for Alzheimer's disease. Neurobiol Aging 17: 359-63
68. Strijbos PJ, Rothwell NJ (1995) Interleukin-1β attenuates excitatory amino acid-induced neurodegeneration in vitro: involvement of nerve growth factor. J Neurosci 15: 3468-74
69. Strittmatter WJ, Roses AD (1995) Apolipoprotein E: emerging story in the pathogenesis of Alzheimer's disease. The Neuroscientist 1: 298-306
70. Van Eldik LJ, Griffin WST (1994) S100β expression in Alzheimer's disease: Relation to neuropathology in brain regions. Biochim Biophys Acta 39: 398-404